Safety and Efficacy of Autoimmune Cell Therapy for Patients With Hepatocellular Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
In this study, safety and effects of IPM001 vaccine on human hepatocellular carcinoma are going to be investigated, IPM001 is a neoantigen/tumor-specific antigen sensitized autoimmune cell injection
Epistemonikos ID: cb861618bfac1619c942b84a14d93fc5c63e66fa
First added on: May 09, 2024